Home »
A type of asthma drug, known as ß2-agonists, can boost sprint and strength performance in athletes who don’t have the respiratory condition, finds a review and pooled data analysis of the available evidence, published online
More than 200 genes with novel and known roles in glioblastoma—the most aggressive type of brain cancer—offer promising new drug targets. Researchers from the Wellcome Sanger Institute, Addenbrooke’s Hospital and their collaborators engineered a new
In their quest to find new drugs to treat deadly diseases, scientists study millions of molecules at high speed at the same time. Often it is enzymes that are investigated as targets in these ‘high-throughput’
Little evidence supports the new recommendations for clinical screening for drug use. Do the potential benefits outweigh the potential harms? In the June 9 issue of JAMA, the U.S. Preventive Services Task Force (USPSTF) recommends
The drug Tagrisso could offer hope to patients battling a form of lung cancer that typically hits people with little or no history of smoking, a new trial finds. Taken after surgery to remove the
Severely ill coronavirus patients were less likely to die and less likely to need life support after just two doses of arthritis drug, new study finds Half of 129 severely ill coronavirus patients received two
Nearly 94% of defendants in Cuyahoga County drug court have been exposed to trauma and many suffer from symptoms of post-traumatic stress disorder (PTSD), according to a new Case Western Reserve University study. “These findings
The net cost of prescription drugs—meaning sticker price minus manufacturer discounts—rose over three times faster than the rate of inflation over the course of a decade, according to a study published today in JAMA. It’s
Scientists in the city at the center of China’s virus outbreak have applied to patent a drug made by U.S. company Gilead Science Inc. to treat the disease, possibly fueling conflict over technology policy that
All type 2 diabetes patient subgroups are likely to achieve cardiovascular protection from the use of SGLT2 inhibitors, according to a large multi-study review published in the Journal of the American Heart Association. Lead author